1600 Amphitheatre Parkway, CA 94043

hero-header USG

9th International Conference on

Cancer Research & Drug Development

November 18-20, 2024 | Boston, MA

RegisterAbstract

Exhibitor

Alfa Cytology

Important Alert: Cancer R&D/USG does not work with any 3rd parties to provide accommodation for this event. Please beware if you receive any e-mails or other communication from 3rd parties informing you about the accommodation options. The only trusted source of information about the accommodation is our website and communication from conference official e-mail address.

About Cancer R&D 2024

Welcome to the 2024 International Conference on Cancer Research and Development (Cancer R&D 2024), a prestigious three-day congress devoted to advancing the field of basic, preclinical, and translational cancer research. Hosted by United Scientific Group, a distinguished non-profit organization committed to the progression of cancer research, Cancer R&D serves as a platform to foster innovation, cultivate knowledge, and encourage meaningful connections and collaborations within the global cancer research community.

Plenary - Keynote Speakers

Sangeeta N Bhatia
Sangeeta N Bhatia

Koch Institute for Integrative Cancer Research At MIT, Howard Hughes Medical Institute

X. Shirley Liu
X. Shirley Liu

Co-founder & CEO
GV20 Therapeutics, MA

Haihui Lu
Haihui Lu

Novartis Institutes for Biomedical Research, MA

Hui Shen
Hui Shen

Van Andel Institute
MI

Douglas R. Green
Douglas R. Green

St. Jude Children's Research Hospital, TN

Raghu Kalluri
Raghu Kalluri

The University of Texas MD Anderson Cancer Center, TX

Robert Weinberg
Robert Weinberg

Founding Member, Whitehead Institute for Biomedical Research, Director, MIT Ludwig Center for Molecular Oncology, Cambridge

A Thomas Look
A Thomas Look

Dana-Farber Cancer Institute
Harvard Medical School, MA

Andrea Califano
Andrea Califano

Columbia University
New York

Andrey Loboda
Andrey Loboda

Director at Merck
Boston

John Quackenbush
John Quackenbush

Harvard T.H. Chan School of Public Health, Boston, USA

Eytan Ruppin
Eytan Ruppin

NCI, National Institutes of Health
MD

Eric B. Kmiec
Eric B. Kmiec

Executive Director & CSO, Gene Editing Institute, ChristianaCare

Ying Xu
Ying Xu

School of Medicine, Southern University of Science and Technology, China

William Douglas Figg
William Douglas Figg

National Cancer Institute, National Institutes of Health

Scientific Sessions

Cancer Progression and Prognosis

Cancer Metastasis

Cancer Resistance

Cancer Microenvironment

The Microbiome and Cancer

Novel Approaches to Detect Cancer Early

Cancer Genetics and Biomarkers

Precision Oncology

Computational Biology and AI in Cancer

Therapeutic Development

Cancer Vaccines

Cancer Immunotherapies: Monotherapy and Combinations

Cellular Therapies for Cancer

Cancer Radiation Therapy

Targeted Therapy

Novel Drug Development in Cancer

Advances in Organ Specific Cancer Research

Breast Cancer

Brain Tumors

Gastrointestinal Malignancies

Non–Small Cell Lung Cancer

Ovarian Cancer

Sarcoma Biology

Neuroendocrine Cancer

Network
Network

Having a great networking is inexpensive. It opens the doors for you and offers you a land of opportunity that might help you to spread your wings. Network face to face building a rapport with someone leading a solid connection in the research you are sailing. Cancer R&D 2023 brings that platform helping to create a foundational trust.

Showcase
Showcase

Research is to see what everybody else has seen but think what nobody else has thought. We at Cancer R&D 2023 created a platform to share that thought. Join us today to present the work to your peers in the world of Cancer Research.

Collaborate
Collaborate

Great achievements and improvements invariably involve the cooperation of many minds. Collaboration allows us to more than we are capable of knowing by ourselves and helps us to think out of box. At Cancer R&D 2023 you will find those minds to collaborate and achieve your goals.

Program
Past Programs

The previous 8 editions of Cancer R&D conference were a great success and has brought together more than 900+ researchers from leading institutes and organizations. Click here

Cancer R&D 2024

Registration

ACADEMIC
$ 999.

  • Welcome coffee
  • Access to All Talks and Posters
  • Conference material
  • Lunch, tea / coffee breaks
  • WiFi in meeting rooms
INDUSTRY
$ 1099.

  • Welcome coffee
  • Access to All Talks and Posters
  • Conference material
  • Lunch, tea / coffee breaks
  • WiFi in meeting rooms
STUDENT
$ 499.

  • Welcome coffee
  • Access to All Talks and Posters
  • Conference material
  • Lunch, tea / coffee breaks
  • WiFi in meeting rooms

Cancer R&D 2024

United Scientific Group has geared up to a next level with its 9th annual meeting on Cancer Research & Drug Development during Nov 18-20, 2024

Contact Us

Subscribe Us


© United Scientific Group.